Showing results (71-80 of 167) with videos related to
Sort By:
Pageof 17
Inorganic Chemistry|December 4, 1996
Synthesis and Characterization by (19)F and (125)Te NMR and Raman Spectroscopy of cis-ReO(2)(OTeF(5))(3) and cis-ReO(2)(OTeF(5))(4)(-), and X-ray Crystal Structure of [N(CH(3))(4)(+)][cis-ReO(2)(OTeF(5))(4)(-)]William J. Casteel, Dianne M. MacLeod, Hélène P. A. Mercier, et al.Chemical Communications (Cambridge, England)|August 7, 2012
SF4·N(C2H5)3: the first conclusively characterized SF4 adduct with an organic baseJames T Goettel, Praveen Chaudhary, Paul Hazendonk, et al.Journal of the American Chemical Society|September 17, 2010
Xe3OF3(+), a precursor to a noble-gas nitrate; syntheses and structural characterizations of FXeONO2, XeF2·HNO3, and XeF2·N2O4Matthew D Moran, David S Brock, Hélène P A Mercier, et al.Journal of Clinical Psychopharmacology|April 1, 1993
Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatientsJ W Stewart, M A Mercier, V Agosti, et al.Clinical Nuclear Medicine|May 1, 1995
Is cardiac migraine a clinical entity?J Lette, L A Mercier, J Lespérance, et al.Angewandte Chemie (International Ed. in English)|February 17, 2025
Xenon Trioxide Coordination Complexes of Crown Ethers: (CH<sub>2</sub>CH<sub>2</sub>O)<sub>4</sub>XeO<sub>3</sub> and Xe(VI) Hydrates, [(CH<sub>2</sub>CH<sub>2</sub>O)<sub>6</sub>(H<sub>2</sub>O)XeO<sub>3</sub>]⋅ H<sub>2</sub>O and [(CH<sub>2</sub>CH<sub>2</sub>O)<sub>6</sub>(H<sub>2</sub>O)XeO<sub>3</sub>]<sub>2</sub> ⋅ 2H<sub>2</sub>O ⋅ HFKatherine M Marczenko, Hélène P A Mercier, James T Goettel, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|November 10, 2021
Noble-Gas Difluoride Complexes of MOF<sub>4</sub> (M=Mo, W); Syntheses, Structures and Bonding of NgF<sub>2</sub> ⋅ MOF<sub>4</sub> and XeF<sub>2</sub> ⋅ 2MOF<sub>4</sub> (Ng=Kr, Xe)Mark R Bortolus, Hélène P A Mercier, David S Brock, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 13, 2019
Xenon Trioxide Adducts of O-Donor Ligands; [(CH<sub>3</sub> )<sub>2</sub> CO]<sub>3</sub> XeO<sub>3</sub> , [(CH<sub>3</sub> )<sub>2</sub> SO]<sub>3</sub> (XeO<sub>3</sub> )<sub>2</sub> , (C<sub>5</sub> H<sub>5</sub> NO)<sub>3</sub> (XeO<sub>3</sub> )<sub>2</sub> , and [(C<sub>6</sub> H<sub>5</sub> )<sub>3</sub> PO]<sub>2</sub> XeO<sub>3</sub>Katherine M Marczenko, James T Goettel, Hélène P A Mercier, et al.Radiologic Clinics of North America|July 28, 2009
CT arthrography, MR arthrography, PET, and scintigraphy in osteoarthritisPatrick Omoumi, Gustavo A Mercier, Frédéric Lecouvet, et al.Prenatal Diagnosis|August 9, 2001
Isolated mild fetal cerebral ventriculomegaly: a retrospective analysis of 26 casesA Mercier, D Eurin, P Y Mercier, et al.Pageof 17